WHSC1L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.050200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.324800E-01
Normal-vs-Stage2
6.529600E-01
Normal-vs-Stage3
1.107380E-01
Normal-vs-Stage4
6.088600E-01
Stage1-vs-Stage2
7.858600E-01
Stage1-vs-Stage3
3.170600E-01
Stage1-vs-Stage4
4.395200E-01
Stage2-vs-Stage3
3.538600E-01
Stage2-vs-Stage4
1.705390E-01
Stage3-vs-Stage4
1.638040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.184800E-01
Normal-vs-AfricanAmerican
6.005000E-01
Normal-vs-Asian
5.041200E-01
Caucasian-vs-AfricanAmerican
9.970200E-01
Caucasian-vs-Asian
7.060400E-01
AfricanAmerican-vs-Asian
7.958600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.300200E-01
Normal-vs-Female
3.957000E-01
Male-vs-Female
3.288800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.623600E-01
Normal-vs-Age(41-60Yrs)
6.243000E-01
Normal-vs-Age(61-80Yrs)
6.021200E-01
Normal-vs-Age(81-100Yrs)
7.366000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.177010E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.384600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.459800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.313600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.771200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.153600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.236200E-01
Normal-vs-Daily Drinker
5.305200E-01
Normal-vs-Weekly Drinker
4.594200E-01
Normal-vs-Occasional Drinker
7.803000E-01
Normal-vs-Social Drinker
3.505200E-01
Non Drinker-vs-Daily Drinker
6.430400E-01
Non Drinker-vs-Weekly Drinker
8.808400E-01
Non Drinker-vs-Occasional Drinker
9.558300E-02
Non Drinker-vs-Social Drinker
4.900000E-01
Daily Drinker-vs-Weekly Drinker
8.228800E-01
Daily Drinker-vs-Occasional Drinker
3.983000E-01
Daily Drinker-vs-Social Drinker
9.229200E-01
Weekly Drinker-vs-Occasional Drinker
3.086200E-01
Weekly Drinker-vs-Social Drinker
7.343800E-01
Occasional Drinker-vs-Social Drinker
3.700600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.324820E-01
Normal-vs-Grade 2
5.385900E-02
Normal-vs-Grade 3
1.230140E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.336400E-02
Grade 1-vs-Grade 3
2.582700E-03
Grade 1-vs-Grade 4
1.324820E-01
Grade 2-vs-Grade 3
2.886400E-01
Grade 2-vs-Grade 4
5.385900E-02
Grade 3-vs-Grade 4
1.230140E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.039800E-01
Normal-vs-NonDiabetic
6.041800E-01
Diabetic-vs-NonDiabetic
4.855000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.117200E-01
Normal-vs-NoPancreatitis
5.956400E-01
Pancreatitis-vs-NoPancreatitis
4.160600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.588800E-01
Normal-vs-N1
5.245200E-01
N0-vs-N1
7.965600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.716400E-01
Normal-vs-TP53-NonMutant
6.028000E-01
TP53-Mutant-vs-TP53-NonMutant
4.061700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
